Combination therapy with caspofungin and amphotericin B lipid complex

被引：13

作者：

Lum, LR ^{[1
]}

Turco, TF

Leone, J

机构：

[1] Univ Sci Philadelphia, Coll Pharm, Philadelphia, PA 19104 USA

[2] Our Lady Lourdes Med Ctr, Dept Pharm, Camden, NJ 08103 USA

[3] Rutgers State Univ, Coll Pharm, New Brunswick, NJ 08901 USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2002年 / 59卷 / 01期

关键词：

D O I：

10.1093/ajhp/59.1.80

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：80 / 81

页数：2

共 6 条

[1] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) [J].

Bartizal, K ;

Gill, CJ ;

Abruzzo, GK ;

Flattery, AM ;

Kong, L ;

Scott, PM ;

Smith, JG ;

Leighton, CE ;

Bouffard, A ;

Dropinski, JF ;

Balkovec, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2326-2332

[2] Echinocandins and pneumocandins - a new antifungal class with a novel mode of action [J].

Denning, DW .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) :611-614

[3] Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro [J].

Franzot, SP ;

Casadevall, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :331-336

[4] Caspofungin acetate: An antifungal agent [J].

Hoang, A .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (13) :1206-1214

[5]

Lomaestro BM, 2001, FORMULARY, V36, P427

[6]

*MERCK, 2001, CANC PACK INS

← 1 →